{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anticancer", "Drug delivery systems", "Ginsenoside Rh(2)", "Mechanisms of action", "Synergistic effect"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36549803", "DateCompleted": {"Year": "2022", "Month": "12", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "26"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1016/S1875-5364(22)60193-6", "S1875-5364(22)60193-6"], "Journal": {"ISSN": "1875-5364", "JournalIssue": {"Volume": "20", "Issue": "12", "PubDate": {"Year": "2022", "Month": "Dec"}}, "Title": "Chinese journal of natural medicines", "ISOAbbreviation": "Chin J Nat Med"}, "ArticleTitle": "Potential of ginsenoside Rh<sub>2</sub>and its derivatives as anti-cancer agents.", "Pagination": {"StartPage": "881", "EndPage": "901", "MedlinePgn": "881-901"}, "Abstract": {"AbstractText": ["As a steroid skeleton-based saponin, ginsenoside Rh<sub>2</sub> (G-Rh<sub>2</sub>) is one of the major bioactive ginsenosides from the plants of genus Panax L. Many studies have reported the notable pharmacological activities of G-Rh<sub>2</sub> such as anticancer, antiinflammatory, antiviral, antiallergic, antidiabetic, and anti-Alzheimer's activities. Numerous preclinical studies have demonstrated the great potential of G-Rh<sub>2</sub> in the treatment of a wide range of carcinomatous diseases in vitro and in vivo. G-Rh<sub>2</sub> is able to inhibit proliferation, induce apoptosis and cell cycle arrest, retard metastasis, promote differentiation, enhance chemotherapy and reverse multi-drug resistance against multiple tumor cells. The present review mainly summarizes the anticancer effects and related mechanisms of G-Rh<sub>2</sub> in various models as well as the recent advances in G-Rh<sub>2</sub> delivery systems and structural modification to ameliorate its anticancer activity and pharmacokinetics characteristics."], "CopyrightInformation": "Copyright \u00a9 2022 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Biotechnology and Bioresources Utilization, Ministry of Education, Dalian Minzu University, Dalian 116600, China."}], "LastName": "Li", "ForeName": "Keke", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Biotechnology and Bioresources Utilization, Ministry of Education, Dalian Minzu University, Dalian 116600, China."}], "LastName": "Li", "ForeName": "Zhongyu", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Biotechnology and Bioresources Utilization, Ministry of Education, Dalian Minzu University, Dalian 116600, China."}], "LastName": "Men", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China."}], "LastName": "Li", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Biotechnology and Bioresources Utilization, Ministry of Education, Dalian Minzu University, Dalian 116600, China. Electronic address: gxjclr@163.com."}], "LastName": "Gong", "ForeName": "Xiaojie", "Initials": "X"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Chin J Nat Med", "NlmUniqueID": "101504416", "ISSNLinking": "1875-5364"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Ginsenosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ginsenosides"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Saponins"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2022", "Month": "5", "Day": "25"}, {"Year": "2022", "Month": "12", "Day": "22", "Hour": "20", "Minute": "57"}, {"Year": "2022", "Month": "12", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "27", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36549803", "10.1016/S1875-5364(22)60193-6", "S1875-5364(22)60193-6"]}}], "PubmedBookArticle": []}